Gait variability in Parkinson's disease: Influence of walking speed and dopaminergic treatment

Neurological Research

Volumn 33, Issue 9, 2011, Pages 959-964

  Bryant, Mon S ^a,b   Rintala, Diana H ^b   Hou, Jyhgong G ^b,c   Charness, Ann L ^a   Fernandez, Angel L ^a   Collins, Robert L ^b,c   Baker, Jeff ^a   Lai, Eugene C ^c,d   Protas, Elizabeth J ^a  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d Methodist Neurological Institutes   (United States)

Author keywords

Gait variability; Levodopa; Parkinson's disease; Walking speed

Indexed keywords

CARBIDOPA PLUS ENTACAPONE PLUS LEVODOPA; CARBIDOPA PLUS LEVODOPA; LEVODOPA;

AGED; ARTICLE; CLINICAL ARTICLE; DOPAMINERGIC SYSTEM; FEMALE; GAIT; HUMAN; MALE; PARKINSON DISEASE; WALKING SPEED;

AGED; ANTIPARKINSON AGENTS; FEMALE; GAIT; HUMANS; LEVODOPA; MALE; PARKINSON DISEASE; WALKING;

EID: 80855129489     PISSN: 01616412     EISSN: 17431328     Source Type: Journal    
DOI: 10.1179/1743132811Y.0000000044     Document Type: Article

References (23)

1. Pedersen SW, Oberg B, Larsson LE, Lindval B. Gait analysis, isokinetic muscle strength measurement in patients with Parkinson's disease. Scand J Rehabil Med 1997;29(2):67-74.
2. Hausdorff JM, Cudkowicz ME, Firtion R, Wei JY, Goldberger AL. Gait variability and basal ganglia disorders: stride-to-stride variations of gait cycle timing in Parkinson's disease and Huntington's disease. Mov Disord 1998;13(3):428-37.
3. Hollman JH, Kovash FM, Kubik JJ, Linbo RA. Age-related differences in spatiotemporal markers of gait stability during dual task walking. Gait Posture 2007;26(1):113-9.
4. Schaafsma JD, Giladi N, Balash Y, Bartels AL, Gurevich T, Hausdorff JM. Gait dynamics in Parkinson's disease: relationship to Parkinsonian features, falls and response to levodopa. J Neurol Sci 2003;212(1-2):47-53.
5. Frenkel-Toledo S, Giladi N, Peretz C, Herman T, Gruendlinger L, Hausdorff JM. Effect of gait speed on gait rhythmicity in Parkinson's disease: variability of stride time and swing time respond differently. J Neuroeng Rehabil 2005;31(2):23.
6. Yamasaki M, Sasaki T, Torii M. Sex difference in the pattern of lower limb movement during treadmill walking. Eur J Appl Physiol Occup Physiol 1991;62(2):99-103.
7. Danion F, Varraine E, Bonnard M, Pailhous J. Stride variability in human gait: the effect of stride frequency and stride length. Gait Posture 2003;18(1):69-77.
8. Grabiner PC, Biswas ST, Grabiner MD. Age-related changes in spatial and temporal gait variables. Arch Phys Med Rehabil 2001;82(1):31-5.
9. Hausdorff JM. Stride variability: beyond length and frequency. Gait Posture 2004;20(3):304.
10. Hoehn M, Yahr MD. Parkinsonism: onset, progression, and mortality. Neurology 1967;17:427-42.
11. Oehlert ME, Hass SD, Freeman MR, Williams MD, Ryan JJ, Sumerall SW. The Neurobehavioral cognitive status examination: accuracy of the 'Screen-Metric' approach in a clinical sample. J Clin Psychol 1997;53:733-7.
12. Fahn S, Elton RL. Members of the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale. In: Fahn S, Marsden CD, Calne DB, Goldstein M, editors. Recent developments in Parkinson's disease. Vol. 2. Florham Park: Macmillan Health Care Information; 1987.
13. Rochester L, Burn DJ, Woods G, Godwin J, Nieuwboer A. Does auditory rhythmical cueing improve gait in people with Parkinson's disease and cognitive impairment? A feasibility study. Mov Disord 2009;24(6):839-45.
14. Hollman JH, Salamon KB, Priest AW. Aged-related differences in stride-to-stride variability during dual task walking: a pilot study. J Geriatric Phys Ther 2004;27(3):83-7.
15. Almeida QJ, Frank JS, Roy EA, Patla AE, Jog MS. Dopaminergic modulation of timing control and variability in the gait of Parkinson's disease. Mov Disord 2007;22(12):1735-42.
16. Morris ME, Iansek R, Matyas TA, Summers JJ. The pathogenesis of gait hypokinesia in Parkinson's disease. Brain 1994;117(Pt 5):1169-81.
17. Rao SM, Harrington DL, Haaland KY, Bobholz JA, Cox RW, Binder JR. Distributed neural systems underlying the timing of movements. J Neurosci 1997;17(14):5528-35.
18. Harrington DL, Haaland KY, Knight RT. Cortical networks underlying mechanisms of time perception. J Neurosci 1998;18(3):1085-95.
19. Morris ME, Iansek R, Matyas TA, Summers JJ. Stride length regulation in Parkinson's disease. Normalization strategies and underlying mechanisms. Brain1996;119(Pt 2):551-68.
20. Yogev G, Giladi N, Peretz C, Springer S, Simon ES, Hausdorff JM. Dual tasking, gait rhythmicity, and Parkinson's disease: which aspects of gait are attention demanding? Eur J Neurosci 2005;22(5):1248-56.
21. Callisaya ML, Blizzard L, Schmidt MD, McGinley JL, Srikanth VK. Ageing and gait variability-a population-based study of older people. Age Ageing 2010;39(2):191-7.
22. Rezak M. Current pharmacotherapeutic treatment options in Parkinson's disease. Dis Mon 2007;53(4):214-22.
23. Hausdorff JM, Purdon PL, Peng CK, Ladin Z, Wei JY, Goldberger AL. Fractal dynamics of human gait: stability of long-range correlations in stride interval fluctuations. J Appl Physiol 1996;80(5):1448-57.